IL1B and atherosclerosis: The overexpression of the IL-1β receptor or exposure to IL-1β increases the progression of atherosclerosis, whereas knockdown of IL-1β or inhibition of IL-1β reduces the biomarkers and lesions associated with atherosclerosis in animal studies.